Huntington director receives stock grants

Huntington Bancshares director Katherine M. A. Kline received additional common stock as part of her compensation.

Rhea-AI Filing Summary

Huntington Bancshares director Katherine M. A. Kline received additional common stock as part of her compensation. On April 1, she was granted 873.994 shares of common stock directly at no cash cost, increasing her direct holdings to 90,416.380 shares.

She also acquired 48.269 common shares credited to a Director Deferred Compensation Plan, bringing her indirect holdings through that plan to 5,020.427 shares. These awards are compensation-related grants rather than open‑market purchases or sales.

Insider Trade Summary

Grant/Award: 922.263 shares

Grant/Award 2 txns

Insider Kline Katherine M. A.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	873.994	$0.00	$0.00
Grant/Award	Common Stock	48.269	$0.00	$0.00

Holdings After Transaction: Common Stock — 90,416.38 shares (Direct); Common Stock — 5,020.427 shares (Indirect, Director Deferred Compensation Plan)

Footnotes (1)

1. F1. The filing of this statement shall not be construed as an admission that the undersigned is, for the purpose of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of the securities.

Key Figures

Direct stock grant: 873.994 shares Indirect stock grant: 48.269 shares Direct holdings after grant: 90,416.380 shares +2 more

5 metrics

Direct stock grant 873.994 shares Common Stock grant to director on April 1

Indirect stock grant 48.269 shares Common Stock credited to Director Deferred Compensation Plan

Direct holdings after grant 90,416.380 shares Total direct Common Stock owned following April 1 awards

Indirect holdings after grant 5,020.427 shares Common Stock held indirectly via Director Deferred Compensation Plan

Grant price per share $0.0000 per share Non-cash equity awards to director

Key Terms

Director Deferred Compensation Plan, Grant, award, or other acquisition, beneficial owner, Section 16

4 terms

Director Deferred Compensation Plan financial

"nature_of_ownership": "Director Deferred Compensation Plan"

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition"

beneficial owner regulatory

"the beneficial owner of the securities."

A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.

Section 16 regulatory

"for the purpose of Section 16 of the Securities and Exchange Act of 1934"

Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Huntington Bancshares (HBAN) report for Katherine M. A. Kline?

Huntington Bancshares reported that director Katherine M. A. Kline received grants of common stock as compensation. She was awarded 873.994 shares directly and 48.269 shares credited to a Director Deferred Compensation Plan, with no cash paid per share for these awards.

How many Huntington Bancshares (HBAN) shares does Katherine Kline hold after this Form 4?

After the reported grants, Katherine Kline holds 90,416.380 Huntington Bancshares common shares directly. She also has 5,020.427 common shares credited indirectly through a Director Deferred Compensation Plan, reflecting equity-based compensation rather than open-market trading activity.

Were the Huntington Bancshares (HBAN) shares on this Form 4 bought or granted?

The Huntington Bancshares shares were granted as compensation, not bought in the market. The Form 4 shows transaction code “A” for grant or award, with a price per share of $0.0000, indicating non-cash equity awards to director Katherine Kline.

What is the Director Deferred Compensation Plan mentioned in the HBAN Form 4?

The Director Deferred Compensation Plan is an arrangement where equity awards are credited indirectly for a director. In this Form 4, 48.269 Huntington Bancshares common shares were allocated to Katherine Kline under this plan, contributing to her 5,020.427 total indirect holdings.

Does the HBAN Form 4 indicate any stock sales by Katherine Kline?

The Form 4 does not report any stock sales by Katherine Kline. It only shows two acquisition transactions coded “A” for grants or awards, adding to her direct and indirect common stock holdings as part of director compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/03/2026 - 01:22 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kline Katherine M. A.

(Last) (First) (Middle)

HUNTINGTON CENTER

41 S. HIGH STREET

(Street)

COLUMBUS OHIO 43215

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HUNTINGTON BANCSHARES INC /MD/ [ HBAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A		873.994	A	$0.0000	90,416.38	D
Common Stock	04/01/2026		A		48.269	A	$0.0000	5,020.427	I	Director Deferred Compensation Plan(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The filing of this statement shall not be construed as an admission that the undersigned is, for the purpose of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of the securities.

	Rachel L. Lawless, Attorney-in-Fact	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)